Neumarker
Founded 2022 · 1 known investors
Neumarker develops AI-based brain biomarkers for central nervous system diseases such as Alzheimer's, depression, and epilepsy. The tools are intended for mental health clinicians and CNS drug developers to guide treatment decisions and support drug development.
AI & Machine LearningBiotechDigital Health
Investors · 1
Frequently asked questions
- What does Neumarker do?
- Neumarker develops AI-based brain biomarkers for central nervous system diseases such as Alzheimer's, depression, and epilepsy. The tools are intended for mental health clinicians and CNS drug developers to guide treatment decisions and support drug development.
- Who are Neumarker's investors?
- Neumarker's investors include Foothill Ventures.